Ionis Closer To First Wholly-Owned Drug Launch With Olezarsen Phase III Success

Drug Targets apoC-III To Lower Triglycerides

 
• By Mandy Jackson
  
Anatomical model of pancreas on doctor table over background gastroenterologist consulting woman patient
A high dose of olezarsen eliminated risk of acute pancreatitis in FCS • Source: Shutterstock

More from Clinical Trials

More from R&D